(Q43000667)

12 November 2017

title

Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin (English)

1 reference

12 November 2017

1 reference

E Rey

1

1 reference

12 November 2017

G E Rivard

series ordinal

2

1 reference

12 November 2017

publication date

1 October 2000

1 reference

International Journal of Gynecology and Obstetrics

12 November 2017

published in

1 reference

12 November 2017

volume

71

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

19-24

1 reference

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Heparin levels to guide thromboembolism prophylaxis during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

Bone density studies in pregnant women receiving heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900290-3

10.1016/S0020-7292(00)00290-3

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference